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S U M M A R Y
Background: Clostridium difﬁcile-associated diarrhea (CDAD) has shown increasing incidence, morbidity,
and mortality in recent years. We assessed the number of CDAD tests requested, CDAD positivity rates,
the use of alcohol-based hand rubs, and antimicrobial utilization.
Methods: We collected information on every adult patient (>18 years) who developed diarrhea and had
a positive stool test for C. difﬁcile toxin from June 2005 to December 2009 at a tertiary care hospital. A
time-series analysis was performed using monthly data on the incidence of C. difﬁcile infection (CDI) (i.e.,
cases of infection per 1000 patient-days), as well as the consumption of alcohol-based hand rubs (in
liters/1000-patient days) and antibiotics (in deﬁned daily doses per 1000 patient-days).
Results: The mean number of annual requests for C. difﬁcile tests was 1031, and the rates per 1000
patient-days for each year from 2005 to 2009 were 0.30, 0.46, 0.39, 0.31, and 0.40 overall in the hospital,
and 0.18, 0.10, 0.53, 0.38, and 0.37 in the intensive care unit (ICU). The use of alcohol-based hand rubs per
1000 patient-days increased from 37.4 to 73.0, and from 41.5 to 129.4 in the hospital and in the ICU,
respectively.
Conclusions: The incidence of CDI in the hospital and ICU remained low, despite the increased use of
alcohol-based hand rubs and antimicrobials.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Clostridium difﬁcile is the main cause of nosocomial diarrhea.1
Attributable costs of inpatient C. difﬁcile infection (CDI) have been
estimated to be $2470 to $3669 per episode.1 CDI has recently been
associated with an attributable mortality rate of 6.9% at 30 days
after diagnosis and 16.7% at 1 year after diagnosis.1,2 Common risk
factors for CDI include increasing age, presence of comorbidities, a
long hospital stay, and antibiotic use.2,3 Given that antibiotic use is
unnecessary or inappropriate in as many as 50% of cases,
interventions to improve antibiotic prescribing can reduce
hospital-acquired infections.4 In addition, CDI reduction has been
shown to be associated with compliance with infection control
measures.5 C. difﬁcile spores can survive after hand hygiene with
alcohol-based antiseptics and routine disinfection of environmen-
tal surfaces.6 The lack of sporicidal activity has led some infection* Corresponding author. Tel.: +55 11 37471500; fax: +55 11 37471500.
E-mail address: moacyrjunior8@hotmail.com (M. Silva Jr).
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http://dx.doi.org/10.1016/j.ijid.2012.12.022control experts to suggest that the observed increase in CDI may be
due to the increased use of alcohol-based hand rubs by healthcare
workers.7 However, at least one study has shown that the
increased use of alcohol-based hand rubs was not associated with
an increase in the incidence of CDI.8 There are very few studies
assessing the correlation between the incidence rate of CDI and the
use of antimicrobials and alcohol-based hand rubs.7,8 In Brazil,
most hospitals do not test stool specimens for C. difﬁcile toxin for
reasons of cost and obtain testing only in outbreak situations.
Therefore, the objective of our study was to assess the incidence
rate of CDI in the hospital overall, as well as in the intensive care
unit (ICU), and to evaluate its potential correlation to the use of
antimicrobials and alcohol-based hand rubs.
2. Patients and methods
2.1. Study design and setting
Our study was conducted in a 530-bed tertiary care, private
hospital that includes the following units: medical–surgical wards,ses. Published by Elsevier Ltd. All rights reserved.
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adult open-model ICU. The hospital admits approximately 30 000
patients per year; the 38-bed ICU admits approximately 2200
patients per year.
In this retrospective observational study we collected informa-
tion on every adult patient (>18 years) who developed diarrhea
and had a positive stool test for C. difﬁcile toxin in the time period
from June 2005 to December 2009. This study was a quality
improvement study that was approved by the Institutional Review
Board of Hospital Israelita Albert Einstein (IRB). The requirement
for informed consent was waived by our IRB in accordance with the
Code of Federal Regulations and the Privacy Rule. Demographic
data and information on patients with documented CDI were
obtained from the daily listings supplied by the Immunology
Department, which reports both positive and negative C. difﬁcile
test results. A descriptive analysis was performed using monthly
data on the incidence of CDI (i.e., cases of infection per 1000
patient-days), as well as the consumption of alcohol-based hand
rubs and antibiotics per 1000 patient-days.
2.2. Deﬁnition of CDI and multidrug-resistant organisms
Cases were identiﬁed by reviewing laboratory reports for
positive stool toxin test results (enzyme immunoassay for C.
difﬁcile toxin with a positive result for A and/or B toxin); no PCR
tests for C. difﬁcile were performed during the study period.
Nosocomial infection was deﬁned as the onset of diarrhea >72 hFigure 1. (A) CDAD incidence and alcohol hand rub consumption from June 2005 to Decem
from June 2005 to December 2009. (CDAD, Clostridium difﬁcile-associated diarrhea; DDafter admission, or pseudomembranous colitis or toxic megacolon
diagnosed >72 h after admission, or positive enzyme immunoas-
say within 72 h of discharge. Relapse of CDI was deﬁned as the
development of diarrhea and subsequent positive C. difﬁcile test
results, or subsequent endoscopy or biopsy results indicating CDI.8
Contact precautions were utilized empirically for all patients
who developed diarrhea until the ﬁnal result of the C. difﬁcile toxin
test was available. When the patient had documented CDI, contact
precautions were maintained and care givers were advised as per
the hospital policy to use chlorhexidine for hand hygiene;
however, no prompts, such as signs recommending the avoidance
of alcohol hand rub, were used.
2.3. Data collection
For each month of the study period, data were collected on
antimicrobial consumption and volume of alcohol-based hand
antiseptics used, patient-days, and number of cases of CDI. Data on
the monthly quantities of all antimicrobial drugs and alcohol-
based hand antiseptics used for hand disinfection delivered to each
inpatient unit were extracted from the pharmacy accounting
system. Antimicrobial consumption was calculated in terms of the
number of deﬁned daily doses (DDD) per 1000 patient-days (based
on the deﬁnition of the World Health Organization Anatomical
Therapeutic Chemical index),9 and the volume of alcohol-based
hand rub solution used was quantiﬁed in liters per 1000 patient-
days. In the hospital, alcohol-based hand antiseptics are theber 2009. (B) CDAD incidence and total antibiotic use (DDD per 1000 patient-days)
D, deﬁned daily doses.)
Table 1
Clostridium difﬁcile testing and CDI incidence during the study period
Location Metric 2005a 2006 2007 2008 2009
All non-ICU wards Stool specimens tested for C. difﬁcile 387 832 822 875 1158
Specimens positive for C. difﬁcile (%) 4.9 6.0 4.7 3.8 4.2
Nosocomial CDI cases 19 50 39 33 49
Admissions 16 804 28 541 27 803 28 917 29 971
Patient days 60 140 101 053 112 071 108 813 122 327
Alcohol-based hand rub use (liters/1000 patient-days) 33.9 42.7 40.9 52.0 68.0
CDI/1000 patient-days 0.32 0.49 0.35 0.30 0.40
ICU Stool specimens tested for C. difﬁcile 115 178 210 275 302
Specimens positive for C. difﬁcile (%) 0.9 0. 6 2.4 1.4 1.3
Nosocomial CDI cases 1 1 5 4 4
Admissions 1206 2226 2296 2448 2578
Patient days 5459 9841 9520 10 366 10 889
Alcohol-based hand rub use (liters/1000 patient-days) 41.5 51.7 66.5 87.7 129.4
CDI/1000 patient-days 0.18 0.10 0.53 0.38 0.37
Total inpatients Stool specimens tested for C. difﬁcile 502 1010 1032 1150 1460
Specimens positive for C. difﬁcile (%) 2.98 4.75 3.39 2.78 3.35
Nosocomial CDI cases 20 51 44 37 53
Admissions 18 010 30 767 30 099 31 365 32 549
Patient days 65 599 110 894 113 021 119 179 133 216
Alcohol-based hand rub use (liters/1000 patient-days) 37.4 43.5 46.2 55.1 73.0
CDI/1000 patient-days 0.30 0.46 0.39 0.31 0.40
30-day crude mortality (%) 20.0 6.2 17.0 0.0 12.0
Outpatients Stool specimens tested for C. difﬁcile 68 145 132 218 310
Specimens positive for C. difﬁcile (%) 7.3 4.8 9.1 7.3 8.1
CDI cases 5 7 12 16 25
CDI, Clostridium difﬁcile infection; ICU, intensive care unit.
a June–December.
Table 2
Use of antimicrobials in DDD/1000 patient-days in the hospital from June 2005 to
December 2009
Antibiotics 2005a 2006 2007 2008 2009
Cephalosporins
Hospital 330.9 349.8 386.8 465.8 484.4
ICU 490 610 508 475 343
NNISSb 281.2
Carbapenems
Hospital 35.6 40.3 45.3 42.3 50.6
ICU 310 188 178 209 282
NNISSb 37.8
Ciproﬂoxacin
Hospital 86.9 163.6 130.7 151.1 64.5
ICU 230 172 83 85 54
NNISSb 205.9
Vancomycin
Hospital 28.9 29.7 26.3 26.6 26.4
ICU 260 165 123 119 108
NNISSb 85.8
Teicoplanin
Hospital 16.4 12.3 17.7 18.4 25.7
ICU 23.1 14.5 20.3 17.5 26.5
NNISS (no data)
Clindamycin
Hospital 24.3 31.6 31.2 32.7 26.6
ICU 36.7 36.4 39.1 33.8 24.7
NNISS (no data)
Metronidazole
Hospital 33.1 48.3 48.6 47.0 47.2
ICU 44.6 61.9 66.2 56.4 38
NNISS (no data)
Linezolid
Hospital 6.8 12.0 13.0 15.9 20.2
ICU 122 100 87.7 79 61.2
NNISS (no data)
DDD, deﬁned daily doses; ICU, intensive care unit; NNISS, National Nosocomial
Infections Surveillance System.
a June–December.
b NNISS value for ICU data.10
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washed with water and plain soap only if they were visibly soiled.
The diagnoses of pseudomembranous colitis and toxic megacolon
were abstracted via chart review by the infection control
personnel. All patients who died within 30 days of the onset of
the infectious episode were evaluated.
Statistical analyses were performed using SPSS 17.0. Quantita-
tive variables are given as the mean and standard deviation, and
qualitative variables in absolute (n) and relative frequencies (%).
3. Results
3.1. CDI
The incidence rate of nosocomial CDI per 1000 patient-days
remained stable over the years, as seen in Figure 1A. The mean
number of annual requests for C. difﬁcile tests was 1031. The
number of C. difﬁcile tests requested increased, and the percentage
of positive tests in the ICU increased from 0.87 in 2005 to 1.32 in
2009 (Table 1). In 2007, CDI incidence in the ICU showed an
increase, but declined in 2009, the year with the highest number of
tests ordered. The number of admissions, both to the hospital and
to the ICU, remained stable for the entire study period (Table 1).
Outpatients had higher rates of C. difﬁcile toxin test positivity
compared to hospitalized patients. The mean age ( standard
deviation (SD)) of hospitalized patients was 63.8 years ( 25.2) and
the median was 74.7 years. For outpatients, the mean age ( SD) was
48.9 years ( 24.4) and the median was 53.1 years. Only one patient
had a recurrent infection. Crude mortality rates within 30 days of the
CDI episode changed over the study period (Table 1).
3.2. Alcohol-based hand rub use (in liters/1000 patient-days) and
antibiotic consumption (in DDD/1000 patient-days)
Over the study period, the use of alcohol-based hand rubs
increased gradually throughout the hospital and particularly in the
ICU (Figure 1A and Table 1). Compared to data from the National
Nosocomial Infections Surveillance System (NNISS),10 we also
observed a heavy use of antimicrobial therapy in the hospitaloverall, and particularly in the ICU (Figure 1B and Table 2).
Speciﬁcally, the use of cephalosporins, carbapenems, and vanco-
mycin were high, whereas the use of ciproﬂoxacin was lower.
Teicoplanin and metronidazole showed higher use in 2009 in the
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increased in the hospital as a whole, during this period, but
decreased in 2009, particularly in the ICU (Table 2).
4. Discussion
The incidence rate of CDI in our hospital and ICU was low,
despite the increased frequency of testing for C. difﬁcile toxin for
every episode of diarrhea, compared to the average rate of 4.6 cases
per 1000 patient-days recorded in Canadian hospitals.11
Our rate of positive tests among outpatients was higher than for
hospitalized patients. Price et al. also reported a high incidence rate
of CDI at admission, i.e., 4.0 cases/10 000 patient-days.12 Loo et al.
found a high mean CDI incidence rate of 22.5 per 1000 patient-days
(range 10.2–39.9).13 A factor potentially related to this rate is the
increased frequency of testing in outpatients developing symp-
toms in the community who are subsequently admitted to the
hospital.12 Our higher rate of CDI in outpatients may be explained,
at least partially, by some of these patients having been
hospitalized recently or having other risk factors prompting
clinicians to test them, such as antibiotic administration and
multiple underlying comorbidities.
Historically, patients with diarrhea at our institution were
routinely tested for C. difﬁcile toxin and placed under empiric
contact precautions until the test report was available. In 2009,
there was an increased number of toxin tests performed in our ICU
patients, nevertheless the incidence rate remained low. Once they
were diagnosed with CDI, the preferred type of hand hygiene was
with chlorhexidine, and patients were kept under contact
precautions for the duration of the diarrhea episode.
We expected to ﬁnd a higher incidence rate of CDI in our
hospital, since our antimicrobial use is nearly 2-fold greater for
third-generation cephalosporins and 5-fold greater for carbape-
nems than in ICUs in the USA.10 Other reportedly effective control
measures may have played a role in halting the spread of CDI, for
example, keeping patients in private hospital rooms, using
dedicated equipment such as stethoscopes, thermometers, and
sphygmomanometers, applying empirical isolation procedures to
all patients with diarrhea, and testing these patients for the
presence of toxin in the stool.5 In almost all situations where CDI
rates increased, changes in antibiotic usage were implemented, in
addition to the enhancement of infection control measures, leading
to a marked reduction in the incidence of CDI.5,14
Over the study period, the use of alcohol-based hand rubs in our
hospital increased signiﬁcantly. Some studies suggest that the use
of alcohol-based hand rubs might be associated with a higher
incidence of CDI, due to the lack of sporicidal activity.1,6 In the
study of Boyce et al., the correlation between the use of alcohol-
based antiseptics and the increased incidence of CDI was assessed,
but no association was found.7 Although some individuals have
voiced concern that the increased use of alcohol-based hand rubs is
responsible for this phenomenon, our ﬁndings and those of several
other studies show that the increased use of alcohol-based hand
rubs over the years has not been associated with an increased
incidence of CDI.6,7 In fact, we detected our lowest incidence of CDI
in 2009, when the use of alcohol-based hand rubs was at its highest
in the ICU. These ﬁndings suggest that, although it may be prudent
to wash hands with non-antimicrobial or antimicrobial soap and
water after removing gloves when caring for patients with
documented CDI, the evidence suggests that alcohol-based hand
rubs are not associated with a higher incidence of CDI.6,7
Another factor associated with a higher rate of new cases and/or
relapses is the emergence of a new strain of C. difﬁcile with
increased virulence and resistance to newer ﬂuoroquinolones.15
Our study found only one case of recurrence; however, the surveywas limited by the absence of strain typing in our sample.
Nevertheless, it has been reported that this hypervirulent strain is
associated with increased incidence, morbidity, recurrence, and
mortality. Most likely our cases were not associated with a
hypervirulent strain. In addition, the overall 30-day crude
mortality rates from CDI in our study were variable and lower
than in some other studies. Other reports, such as that of Loo et al.,
found a high 30-day crude mortality rate due to this strain
(24.8%).13
Our study had some limitations, such as being conducted at a
single medical center with results that may not be generalizable to
other healthcare institutions, as well as being a descriptive study
and not assessing risk factors or correlations for C. difﬁcile-
associated diarrhea or death.
The results of our study suggest that despite testing all patients
with diarrhea for C. difﬁcile toxin, the extensive use of antibiotics in
the hospital, and the increased consumption of alcohol gel for hand
hygiene, the incidence of CDI in the hospital and ICU remained low.
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